OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Blautia—a new functional genus with potential probiotic properties?	685
Gut Bacteroides species in health and disease	563
The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health	347
Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice	280
Intestinal Cetobacterium and acetate modify glucose homeostasis via parasympathetic activation in zebrafish	224
Oscillospira - a candidate for the next-generation probiotics	214
The impact of the gut microbiota on the reproductive and metabolic endocrine system	212
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease	197
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease	194
The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice	193
Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health	173
Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elde	165
Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain	150
Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity	143
Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development	141
Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice	141
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis	138
Epigenetic regulation by gut microbiota	131
Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis	127
B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling	124
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	123
Microbiota-derived metabolites as drivers of gut–brain communication	122
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases	119
The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis	118
Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization	117

From correlation to causality: the case of Subdoligranulum	115
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial	114
Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics	101
The interplay between Helicobacter pylori and gastrointestinal microbiota	98
Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice	96
Iron homeostasis in host and gut bacteria – a complex interrelationship	94
Emerging issues in probiotic safety: 2023 perspectives	93
Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid	92
Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis	91
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis	91
Bacteroides-dominant gut microbiome of late infancy is associated with enhanced neurodevelopment	89
Integrated gut virome and bacteriome dynamics in COVID-19 patients	88
Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis	84
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota	78
The intestinal microbiota and metabolites in patients with anorexia nervosa	76
Bile acids as modulators of gut microbiota composition and function	75
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay	75
Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis	72
Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family	72
Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway	72
Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls	71
Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease	71
The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial	70
Altered gut bacterial and metabolic signatures and their interaction in gestational diabetes mellitus	70
Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat	69
Resistant starch, microbiome, and precision modulation	68
Dietary vitamin K is remodeled by gut microbiota and influences community composition	66
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	66
Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome	66
Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression	66
Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome– a pilot study	64
Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats	62
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR	60
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19	60
Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader	59